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It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
nature publishing group
High glucose induces 
HIF-1α in mesangial cells
Diabetic glomerulosclerosis is assoc­
iated with a number of overexpressed 
genes in the glomerulus. One gene that 
is receiving much attention is vascular 
endothelial growth factor (VEGF). Isoe et 
al. studied whether glucose alone could 
mediate an increase in expression of the 
transcription factor known to regulate 
these angiogenic factors, hypoxia­induc­
ible factor­1α (HIF­1α). They incubated 
mesangial cells with high glucose and 
found that it upregulated HIF­1α even 
though the oxygen tension was constant. 
Some of its target genes were assayed and 
were also upregulated. In mice made dia­
betic with streptozotocin, the abundance 
of HIF­1α was also increased in the 
nucleus. How could this signal be trans­
duced in the absence of hypoxia? The 
authors found that a glucose­responsive 
carbohydrate response element binding 
protein (ChREBP), known to activate 
HIF­1α, was then knocked down by 
siRNA in mesangial cells. They found 
that high glucose no longer increased 
the expression of HIF­1α. These find­
ings begin the analysis of a nice pathway 
and will hopefully lead to more studies 
to see whether it is involved in the gen­
esis of human diabetic nephropathy. 
See page 48.
MMP-2 mediates 
angiotensin receptor 
blocker-induced 
regression
Hayashi et al. treated mice that had 
adriamycin­induced glomerulosclerosis 
with angiotensin receptor blockers and 
found that treatment induced regres­
sion of the sclerosis. A 2­week course of 
candesartan caused a dose­dependent 
regression of established glomerulo­
sclerotic lesions sustained for over 6 
months following cessation of treat­
ment. The authors found that matrix 
metalloproteinase (MMP)­2 activity 
was increased in the glomerulus after the 
angiotensin blocker therapy. The regres­
sion of glomerulosclerosis was partially 
attenuated in mice pretreated with the 
MMP inhibitor doxycycline, as well as 
in MMP­2 knockout mice. These studies 
suggest that MMP­2 is downstream of 
the receptor blockers and likely mediates 
the regression. See page 69.
Uremia causes 
resistance to growth 
hormone through 
defects in  
STAT signaling
Uremia is associated with resistance to 
growth hormone (GH) and to insulin­
like growth factor­1 (IGF­1). Chen et al. 
examined the involvement of the JAK/
STAT pathway in this resistance. They 
found that GH­induced activation of 
this pathway was blunted in uremia. 
Further, they ascertained that hepatic 
STAT5b phosphorylation was impaired 
and that the binding of phospho­STAT5b 
to DNA was reduced, thereby reducing 
IGF­1 gene expression. They found simi­
lar results when endotoxin was admin­
istered to model states of inflammation. 
Here, endotoxin reduced IGF­1 and 
GH resistance by a similar mechanism. 
These results suggest that resistance to 
GH­induced IGF­1 expression in uremia 
arises due to defects in phosphorylation 
of STAT5b and to its impaired binding 
to DNA, processes further aggravated by 
inflammation. See page 89.
